Dr. Jeffrey R. Jay, M.D. »

Eliem Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 248k 5.09

More positions owned by Dr. Jeffrey R. Jay, M.D.

Neurogene (NGNE)
Abivax Sa Sponsored Ads (ABVX)
Pliant Therapeutics (PLRX)
Evolus (EOLS)
Miragen Therapeutics (VRDN)
Arcellx Common Stock (ACLX)
Cytokinetics Com New (CYTK)
Kalvista Pharmaceuticals (KALV)
Dynavax Technologies Corp Com New (DVAX)
Context Therapeutics (CNTX)
Zura Bio Class A Ord Shs (ZURA)
Oruka Therapeutics
Merus N V (MRUS)
Olema Pharmaceuticals (OLMA)
Ionis Pharmaceuticals (IONS)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
BlackRock
Affinity Asset Advisors
Driehaus Capital Management
Geode Capital Management
Nan Fung Group Holdings
BlackRock
Vanguard Group
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management

View all funds holding Eliem Therapeutics